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ABSTRACT
Achalasia is a rare motility disorder caused by an incomplete relaxation of the lower 
esophageal sphincter and loss of esophageal peristalsis. As a consequence, the bolus 
swallowing is hindered and the patients complain dysphagia, regurgitation, chest pain, 
respiratory symptoms and weight loss. Achalasia’s treatment has been varied over time, 
from therapies aiming to relax the lower sphincter of the esophagus, including drugs and 
Botox injection or mechanical dilatations, to surgical myotomy. Robotic or laparoscopic 
Heller-Dor procedure is considered the gold standard surgical treatment for symptomatic 
achalasia as it is proved to be effective and safe.
As an alternative, Per-Oral Endoscopic Myotomy (POEM) was applied over the past 
decade, aiming to combine the same results of mini-invasive procedure to the advantages 
of endoscopic approach.
In this study, we are going to compare the medium-long term results of mini-invasive 
Heller-Dor procedure, routinely performed in our Department, with those of POEM 
reported in literature.
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Background:
Esophageal achalasia is a primary motility disorder 
characterized by an incomplete relaxation of the lower 
esophageal sphincter and the absence of peristalsis. 
Therefore, patients complain with obstructive symptoms 
like dysphagia, regurgitation, chest pain and weight loss. 
Respiratory manifestations such as nocturnal cough, 
dyspnea and pneumonia may occur in advanced stages. 
Achalasia is a chronic disease that leads to loss of 
functional properties and anatomical alterations of the 
esophagus; usually it is not diagnosed in early phases, 
but it is important to recognize it before some irreversible 
changes occur [1]. 
Obstructive symptoms are suggestive for the diagnosis, 
which can be confirmed by instrumental exams such 
as esophageal manometry, fluoroscopy with contrast 
swallow and endoscopy. According to 2019 Seoul 
Consensus on Esophageal Achalasia Guidelines, 
manometry is considered essential for the diagnosis and 
neither fluoroscopy nor EGD are sensitive enough to 
confirm the disease [1]. 
Currently, a specific therapy targeting the causative 
mechanism of achalasia is not available, since its 
pathophysiology is unknown; hence, treatment of 
achalasia aims to palliate dysphagia and possible 
associated complications by reducing esophagogastric 
junction (EGJ) pressure, in order to allow the passive 
transit of the bolus into the stomach [1-3].
Oral drugs reducing LES pressure are administered to 
patients unsuitable for endoscopic or surgical procedures 
and their effect is temporary, from 90 minutes of nitrates 
to 120 minutes of calcium channel blockers. Also, 
botulinum toxin injection shows short-term benefits; 
however, in patients with poor general conditions, 
repeated administration should be considered [1].
Pneumatic balloon dilatation (PD) is a valuable 
alternative to surgical treatment of achalasia, as it 
can provide good long-term results according to 
retrospective analysis [1]. However up to 30% of patients 
experience gastroesophageal reflux after dilatation, 
which may cause recurrent LES stenosis and dysphagia 
[4]. Nevertheless, many studies report that PD is as 
effective as surgical treatment, i.e. Heller-Dor myotomy, 
even after 2 years of follow up, while some authors find 
outcome differences according to achalasia severity, 
being surgical intervention more effective in symptoms 
remission rate than dilatation for more severe disease 
manifestations [1].
Heller-Dor myotomy requires full-thickness section of 
the muscular layers of the esophagus, extended 5 cm 
above the EGJ and 2 cm onto the stomach. Usually, the 
myotomy is followed by Dor fundoplication to prevent 
gastro-esophageal reflux onset [5].
Heller-Dor procedure performed in mini-invasive 
fashion is nowadays considered the gold standard 
approach for primary treatment of fit-for-surgery 
patients affected by achalasia or for patients not 
responsive to pharmacological or endoscopic therapies 
[5,6].
With technological improvement, robotic Heller-
Dor (RAHD) has gained more interest thanks to the 
implementation of stereoscopic tridimensional optical 
system and dexterity, increasing surgeon’s sensibility 
in performing the myotomy and reducing possible 
complications such as gastroesophageal perforation 
compared to laparoscopic approach. In this regard, 
Kim et al. [7] confirmed a less frequent iatrogenic 
gastroesophageal perforation with robotic approach 
and observed a reduced incidence of recurrent achalasia, 
due to the agility conferred by wrist-like movements of 
robotic tools, which allow to better peel muscle fibers 
laterally preventing them from healing together. 
Recent advantages in endoscopic procedures, which are 
even less invasive and painful than surgical interventions 
performed laparoscopically, have introduced a novel 
technique of Per-Oral Endoscopic Miotomy (POEM) 
among the therapeutic options for achalasia. It is an 
advanced endoscopic procedure which consists in 
creating a submucosal tunnel from the middle third of 
the esophagus to the proximal stomach, followed by 
a myotomy extended from 2 cm below initial mucosal 
incision towards the cardia [8,9]. At the beginning POEM 
was criticized for the absence of any anti-reflux valve 
system confection, which may result in post-procedural 
gastro-esophageal reflux occurrence.  Recently, POEM 
results in terms of success rate, adverse effects and post-
procedural reflux onset have been evaluated by many 
systematic reviews and metanalyses, showing the non-
inferiority of this technique to surgical Heller-Dor [10-
13].
Hence, we present our 10-year experience in the 
treatment of achalasia with RAHD, submitting our 
surgical and functional results aiming to compare them 
to those of POEM reported in literature. 
Methods:
Patients treated with robot-assisted Heller-Dor myotomy 
(RAHD) in our Department of General Surgery, IRCCS 
Policlinico San Matteo, Pavia, from January 2010 to 
January 2020 were retrospectively extracted from 
informatic database. All patients were diagnosed with 
esophageal achalasia based on clinical presentation and 
radiological or manometrical preoperative exams.
Data regarding preoperative clinical characteristics, 
intraoperative and post-operative information were 
collected, therefore including age, sex, BMI, ASA score, 
operative time, previous surgical interventions and 
complained symptoms. 
With the aim to objectify the severity of dysphagia 
and others achalasia related symptoms Eckardt score 
(ES) was used, which assigns a score from 0 to 3 on 
the basis of patient’s self-reported response to four 
main disease manifestations (dysphagia, regurgitation, 
chest pain and weight loss), resulting in a total score 
ranging from 0 to 12.  Follow up was accomplished via 
telephone on April 2020 administering ES again along 
with Gastroesophageal Reflux Disease Questionnaire 
(GERD-Q) to evaluate potential achalasia recurrence 
or reflux disease late onset [14]. GERD-Q assesses the 
probability of having gastro-esophageal reflux (RE) 
considering symptoms like heartburn, regurgitation, 
epigastric pain, nausea, sleep disorders and use of PPI 
and rating them from 0 to 3 score. The final score ranges 
from 0 to 18; many studies suggest that the higher is 
the score, the greater is the possibility of RE. Moreover, 
further studies demonstrate that the risk of reflux is low 
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when GERD-Q is smaller than 8 [15].
Results obtained from statistical analysis of our data 
were matched with those obtained after RAHD and 
POEM reported in literature so far. 
Results
During the study period, a total of 55 patients were 
treated with RAHD myotomy, 27 males and 28 females, 
with a mean age of 57,1 ± 19,1 years.
The mean ASA score was 1,85 ± 0,67, being ASA 2 class 
mostly represented (29 patients, 52,2%); mean body mass 
index (BMI) was 23,4 ± 9,66 Kg/m2. Mean operative 
time was 165 ± 40,5 min. Neither intraoperative nor 
postoperative complications were recorded, except 
for one episode of recurrent vomiting following diet 
reintroduction in a patient with megaesophagus affected 
by esophageal candidiasis, successfully managed 
conservatively. Mean hospital stay after surgery was 
4,5 ± 3 days; most patients were discharged in third 
POD (20, 36,3%). Only the aforementioned patient was 
discharged after 25 days after surgery.
Mean Eckardt score administered preoperatively to 53 
on 55 patients was 8,2 ± 1,7 (range 3-12). 
Follow-up lasted from 3 to 87 months, with an average 
of 36,7 ± 26,2 months. 2 patients died and 3 were lost 
to follow-up. Therefore, post-operative questionnaires 
were administered to 50 on 55 patients. Mean post-
operative Eckardt score was 1 ± 1,53, resulting in a good 
symptoms resolution after surgical procedure during the 
follow up period examined. The difference between pre 
and post-operative Eckardt score is 7 that is statistically 
significative (p < 0,001). 
Mean GERD-Q score was 6 ± 0.91, ranging from a 
minimum of 5 and a maximum of 10: in particular, 29 
(58%) patients were assigned a score of 6, 11 (22%) a 
score of 7, 5 (10%) a score of 5, 4 (8%) a score of 8 and 1 
(2%) a score of 10. Considering 8 points as a cut off for 
RE diagnosis, we concluded that 5 patients (10%) of our 
case study treated with robotic Heller-Dor procedure 
suffered from post-operative gastro-esophageal reflux.
Discussion
Robotic Heller-Dor myotomy is a safe and feasible 
procedure for the treatment of achalasia. Technological 
innovations introduced by robotic surgery such as 
tridimensional magnified image and articulated 
instruments allowed a reduction of intraoperative 
complications (i.e. perforations) and better results in 
terms of symptoms relief than laparoscopic approach. 
A monocentric study by Pallabazzer et al. [16] showed 
no intraoperative complication in a series of 66 patients 
undergone to RAHD; the same results were reported by 
Galvani et al [17]. Indicative is a multicentric study by 
Melvin and colleagues [18] who submitted a series of 104 
robotic Heller-Dor without a single case of perforations. 
Kim et al. [7] described only one esophageal perforation 
on a series of 37 patients treated with robotic approach 
and 4 perforations in the laparoscopic group; three of 
these patients required conversion to open surgery. 
Our study reflects the results reported in literature as 
we described no intraoperative complications and no 
need to laparotomic conversion. Moreover, we did not 
face any postoperative complications requiring surgical 
reintervention, consistent with other studies’ results.
All patients of our series interviewed at follow up 
declare dysphagia resolution, which is reflected also 
by the significative reduction of the Eckardt score (p < 
0,001). This ES decrease is observable also in 26 patients 
with > 24 months follow-up, whose mean ES was 1, 
suggesting a long-term results maintenance. Perry et al. 
[19], who described dysphagia relief even after 9 years of 
follow up in 84% of patients, support long-term efficacy 
of RAHD.
Up to now, probably due to the rarity of the disease, 
there are only few studies with small cohort of patients 
comparing outcomes of LHM vs POEM; even more so, 
studies comparing benefits and results of RAHD vs 
POEM are less. A recent retrospective study evaluating 
the intra-operative advantages, short-term and long-term 
results of robotic vs laparoscopic Heller Dor, showed a 
lower incidence of intraoperative complications, such as 
perforation and a lower rate of achalasia recurrence with 
robotic technique [19]. According to this, it would be 
expected that RADH would show better results at least 
in terms of intraoperative adverse events than LHM 
when compared to POEM.
A multicenter, randomized controlled trial comparing 
112 POEM and 109 LHM plus Dor fundoplication stated 
a comparable success rate at 2 years follow up but a 
higher incidence of intraoperative complications in 
LHM group (7,3% vs 2,7%) [20]. This is true when POEM 
is performed by experienced endoscopists: in fact, Ren 
et al. [21] showed a higher complication rate in POEM, 
probably due to learning curve. On the other hand, more 
trained endoscopists like Inoue et al. [22] and Zhang et 
al. [23] showed a very low complication rate (3,2% and 
3,3% respectively). 
However, a review by Crespin and colleagues [6] 
reported a variable rate of complications with POEM 
from 0 to 30%; according to a 2018 review by Parsa et al. 
[24], the incidence of adverse effects after POEM varies 
from 0 and 72,2%. This great variability can be explained 
by the heterogeneity of studies reporting adverse effects 
and different definitions of complications used. Major 
complications are emphysema, pneumoperitoneum, 
mediastinal emphysema, and pneumothorax that are 
generally recognized and managed during the procedure 
without sequelae. Again, a comprehensive multicenter 
study of 1826 patients undergone POEM reports a 
complication rate of 7,5%, 0,5% of which of severe entity 
and concludes that POEM is a safe procedure when 
performed by expert operators in tertiary centers [25].
The efficacy of POEM in relieving dysphagia and other 
achalasia-related symptoms is well known by now. 
Previous metanalyses by Akintoye and colleagues [26] 
reported a clinical success rate of 98% at 12 months of 
follow up, defined by an ES reduction from 6.9 to 1. 
In 2019 Consensus on esophageal achalasia guidelines 
the efficacy rate was 92,8% [1]; other meta-analyses 
concluded that POEM has the same efficacy of LHM, 
even in long-term follow up (87% after a median follow 
up of 49 months) [27]. The incidence of postoperative 
RE following POEM is a matter of debate. Many studies 
aiming to evaluate this complication report variable 
results depending on the modality of detecting RE 
(clinic, Ph-testing, endoscopy); a recent meta-analysis 
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reports a post-POEM reflux rate from 7,5 to 47% 
whereas in surgical myotomy reflux rate ranges from 
5,6% to 43%, statistically not different [28]. In our series, 
only 5 patients (10%) complained with symptoms 
ascribable to esophageal reflux reflected by a GERD-Q 
score ≥ 8. However, a dissociation between symptoms 
of gastroesophageal reflux and endoscopic esophagitis 
findings is present: one of the meta-analyses with the 
largest number of patients concluded that both POEM 
and surgical myotomy plus Dor fundoplication cause 
comparable rates of post-procedural reflux-related 
symptoms, but there was a greater number of patients 
with esophagitis endoscopically detected in POEM 
group (22,4% vs 11,5%) [29].
Recently, POEM has been considered as a rescue 
endoscopic therapy for patients who failed surgical 
Heller-Dor, reporting high success rate in terms of 
dysphagia’s resolution in many studies [30,31]. In 
fact, redo Heller-Dor is a challenging procedure due 
to fibrosis and adhesions from the previous surgery 
which may lead to intraoperative complications such as 
gastroesophageal perforation; endoscopic reintervention 
allows to overcome these issues, reducing operative time 
and blood loss and to access to the entire esophagus in 
order to perform longer myotomy if needed [32].
Conclusions
POEM proved to be an effective technique in relieving 
major symptoms of achalasia with a success rate 
comparable to Heller-Dor procedure.
However, we believe that some considerations need to 
be addressed.
Incision-free nature of POEM is believed to be the 
main advantage over laparoscopic or robotic approach, 
since it can overcome post-operative pain of surgical 
procedures. In our experience, patients after RAHD 
usually complain with weak and short-lasting pain, 
perfectly manageable with analgesics and they can get 
up from bed by the same afternoon/evening. Besides, 
patients are safely given liquid diet in POD 1 and solid 
diet in POD 2 and they are discharged on POD 3.
Post-procedural care after POEM is different according 
to clinicians’ attitude: some practitioners perform 
gastrografin swallow study to check integrity of mucosal 
suture and give patients soft diet for at least two weeks 
before starting a regular diet; others discharge patients 
on POD 1, even if some patients feel well enough to leave 
in the evening; they reserve X-ray with gastrografin 
swallow to patients complaining with more pain than 
expected, in case of dysphagia persistence or challenging 
mucosal suturing [8]. 
It is evident that post-operative management after 
RAHD is more standardized in Italy and worldwide, 
as a consequence not only of the longer experience with 
this approach but also of the low probability to incur late 
complications such as bleeding or perforation which, on 
the other hand, may occur with clips abruption after 
POEM.
Moreover, is well recognized that POEM is a complex 
procedure reserved to experienced endoscopists and 
that should be performed in high volume centers only 
in order to guarantee the best outcome for patients. 
Endoscopists must be an expert in esophageal pathology 
and must be familiar with main operative procedures 
such as submucosal dissection as well as being able to 
face intraprocedural complications [9,21,24,33].
Training process should start from watching the 
procedure performed by more experienced operators 
familiarizing with required equipment. Thereafter, 
endoscopists should perform POEM on animal models 
to develop the necessary skills until they can access to 
tertiary centers [34].
In Italy there are few referral centers focused on POEM 
as achalasia in mainly treated surgically; the Da Vinci 
Si robotic system is widely spread on national area and 
its use is mainly intuitive without long and demanding 
training. The availability of double console allows 
training of naïve surgeons, enabling them to perform 
some easy surgical steps of Heller-Dor procedure that 
lacks of particular critical issues after all.
Most studies mentioned before report comparable 
esophageal reflux rate after POEM and Heller Dor; 
however, these results are conditioned by different 
methods to test the actual reflux presence and therefore 
objective studies are strongly recommended [24]. 
Anyway, the section of the lower esophageal sphincter 
predisposes to reflux especially if it isn’t associated to 
anti-reflux valve; in this way, it is reasonable to think 
that almost the totality of patients undergoing POEM 
suffers of RE, regardless of whether it is symptomatic or 
not, with high probability to develop reflux associated 
complications.
For these reasons, we do not consider POEM as a 
convenient alternative technique to surgical Heller-Dor 
as it does not bring remarkable advantages in terms of 
effectiveness, intra e post-procedural complications, 
reflux rate, operative time and technical ease compared 
to RAHD. However, we agree with POEM as a rescue 
procedure after Heller-Dor’s failure, as it allows the 
operator to revise the site of myotomy without encounter 
the difficulties related to previous surgery.
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